ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Up ∞ in July

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 107,454 shares, a growth of ∞ from the June 30th total of 0 shares. Based on an average daily trading volume, of 210,818 shares, the short-interest ratio is currently 0.5 days.

ProtoKinetix Price Performance

Shares of PKTX stock remained flat at $0.00 on Wednesday. The stock had a trading volume of 2,464 shares, compared to its average volume of 152,084. ProtoKinetix has a 12 month low of $0.00 and a 12 month high of $0.01. The firm’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.